Velox Q1 2018 Newsletter

24 April 2018
5 Views
Comments are off for this post

Right off the bat, we will tell you that this Velox newsletter is different from the previous ones. We will be talking about UTI (Urinary Tract Infection) and a huge clinical milestone that Velox has completed: a blinded clinical feasibility study with 26 patient samples for a rapid UTI diagnostic product. So why should we (and you) be excited about this news? Click here to read our Q1 2018 Newsletter.